Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CORCEPT THERAPEUTICS INC Director's Dealing 2012

Dec 6, 2012

30681_dirs_2012-12-06_34ffd0da-6dfc-4728-9457-0a84fc7a1917.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CORCEPT THERAPEUTICS INC (CORT)
CIK: 0001088856
Period of Report: 2012-12-04

Reporting Person: BAKER G LEONARD JR (Director, 10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2012-12-04 Common Stock P 11000.0000 $1.4469 Acquired 11000.0000 Indirect
2012-12-05 Common Stock P 4200.0000 $1.4994 Acquired 15200.0000 Indirect
2012-12-04 Common Stock P 3500.0000 $1.4469 Acquired 3500.0000 Indirect
2012-12-05 Common Stock P 1400.0000 $1.4994 Acquired 4900.0000 Indirect
2012-12-04 Common Stock P 34000.0000 $1.4469 Acquired 34000.0000 Indirect
2012-12-05 Common Stock P 12931.0000 $1.4994 Acquired 46931.0000 Indirect
2012-12-04 Common Stock P 14500.0000 $1.4469 Acquired 14500.0000 Indirect
2012-12-05 Common Stock P 5600.0000 $1.4994 Acquired 20100.0000 Indirect

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 683621.0000 Direct
Common Stock 1185850.0000 Indirect
Common Stock 29273.0000 Indirect
Common Stock 74113.0000 Indirect
Common Stock 5316967.0000 Indirect
Common Stock 1210498.0000 Indirect

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.42 to $1.50, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

F2: Shares held by an irrevocable trust for the benefit of the Reporting Person's grandchild and of which the Reporting Person serves as co-trustee.

F3: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.49 to $1.50, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

F4: Shares held by an irrevocable trust for the benefit of the Reporting Person's grandchild and of which the Reporting Person's child serves as trustee. The Reporting Person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or any other purpose.

F5: Shares held by a limited partnership of which the reporting person is a trustee of a trust which is the General Partner. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein.

F6: Shares held by Sutter Hill Entrepreneurs Fund (AI), L.P. The reporting person is a Managing Director of the General Partner of Sutter Hill Entrepreneurs Fund (AI), L.P. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest in the partnership.

F7: Shares held by Sutter Hill Entrepreneurs Fund (QP), L.P. The reporting person is a Managing Director of the General Partner of Sutter Hill Entrepreneurs Fund (QP), L.P. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest in the partnership.

F8: Shares held by Sutter Hill Ventures, A California Limited Partnership. The reporting person is a Managing Director of the General Partner of Sutter Hill Ventures, A California Limited Partnership. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest in the partnership.

F9: Shares held by a trust of which the reporting person is a trustee. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest in the trust.